2575 — Xuanzhu Biopharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$9.27bn
- HK$8.52bn
- CNY51.77m
Annual cashflow statement for Xuanzhu Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -301 | -556 | -246 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 58.3 | 403 | 6.19 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 94.1 | -7.45 | -0.7 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -116 | -127 | -210 |
| Capital Expenditures | -146 | -80.2 | -42.6 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 191 | 212 | 154 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Sale of Intangible Assets | |||
| Cash from Investing Activities | 44.7 | 132 | 112 |
| Financing Cash Flow Items | -2.33 | -7.16 | -35.7 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -9.9 | -12.4 | 622 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -81.2 | -7.64 | 517 |